Koers Titan Pharmaceuticals, Inc. OTC Bulletin Board
Aandelen
TTNP
US8883141017
Farmaceutische producten
Omzet 2022 | 557K 512K | Omzet 2023 | 184K 169K | Marktkapitalisatie | 6,21 mln. 5,71 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -10 mln. -9,19 mln. | Nettowinst (verlies) 2023 | -5 mln. -4,6 mln. | EV/omzet 2022 | 15,6 x |
Nettoliquiditeiten 2022 | 2,75 mln. 2,53 mln. | Nettoliquiditeiten 2023 | 6,2 mln. 5,69 mln. | EV/omzet 2023 | 0,11 x |
K/w-verhouding 2022 |
-1,03
x | K/w-verhouding 2023 |
-1,11
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 54,53% |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Avraham Ben-Tzvi
BRD | Director/Board Member | 53 | 15-08-22 |
Gim Shen Seow
CEO | Chief Executive Officer | 42 | 12-10-23 |
Brynner Chiam
BRD | Director/Board Member | - | 12-10-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+42,83% | 748 mld. | |
+34,11% | 598 mld. | |
-5,70% | 356 mld. | |
+18,06% | 325 mld. | |
+4,63% | 283 mld. | |
+17,02% | 245 mld. | |
+9,26% | 211 mld. | |
-4,21% | 209 mld. | |
+2,43% | 166 mld. |